首页> 外文期刊>Nephron >Inhibitory Effects of Ligustrazine, a Modulator of Thromboxane-Prostacycline-Nitric Oxide Balance, on Renal Injury in Rats with Passive Heyman Nephritis
【24h】

Inhibitory Effects of Ligustrazine, a Modulator of Thromboxane-Prostacycline-Nitric Oxide Balance, on Renal Injury in Rats with Passive Heyman Nephritis

机译:川gust嗪(一种调节血氧烷-前列环素-一氧化氮平衡的调节剂)对被动性Heyman肾炎大鼠肾损伤的抑制作用

获取原文
获取原文并翻译 | 示例
           

摘要

Aims: To explore the effects of ligustrazine on protein-uria, urinary TxB_2 (metabolism of thromboxane A_2, TxA_2) and 6-keto-PGF_(1alpha)(metabolism of prostacyclines l_2, PG l_2), glomerular inducible nitric oxide(NO) synthase (iNOS) mRNA, urinary NO_3~-/NO_2~- (decomposing products of NO) and pathological changes in rats with passive Heymann nephritis (PHN). Methods: A rat PHN model was induced by intravenous injection of rabbit anti-rat renal tubular antigen (Tub-Ag) antiserum, and ligustrazine was given intraperitoneally into PHN rats every 2 days for 1-5 weeks. Then, proteinuria, urinary TxB_2 and 6-keto-PGF_(1alpha), glomerular iNOS mRNA, and urinary NO_3~-/NO_2~- were measured by sulfosalicylic acid, radioimmunoassay (RIA), Northern blot and nitric acid reductase methods, respectively. Moreover, the damage to the renal tissue of the rats was observed under light and electron microscopy and immunofluorescence (IF). Results: The urinary TxB_2 in PHN rats was significantly higher than that in control rats, but the PHN rats treated with ligustrazine had significantly less proteinuria, urinary TxB_2 and tissue lesions, and more urinary 6-keto-PGF_(1alpha), glomerular iNOS mRNA and urinary NO_2~-/NO_3~- than the PHN rats without the administration of ligustrazine. Conclusion: These data indicate that ligustrazine has inhibitory roles on the glomerular injury of PHN rats, which may associate with modulating the balance of TxA_2-PGI_2 and elevating synthesis of NO to a certain extent.
机译:目的:探讨川gust嗪对蛋白尿,尿中TxB_2(血栓素A_2,TxA_2的代谢)和6-酮-PGF_(1alpha)(前列环素l_2,PGl_2的代谢),肾小球诱导型一氧化氮合酶的影响被动Heymann肾炎(PHN)大鼠的(iNOS)mRNA,尿液NO_3〜-/ NO_2〜-(NO分解产物)和病理变化。方法:静脉注射兔抗大鼠肾小管抗原(Tub-Ag)抗血清,建立大鼠PHN模型,每2天腹腔注射川gust嗪1-5周,每次2天。然后,分别通过磺基水杨酸,放射免疫法(RIA),RNA印迹法和硝酸还原酶法测定了蛋白尿,尿中的TxB_2和6-酮-PGF_(1α),肾小球的iNOS mRNA和尿中的NO_3-// NO_2-。此外,在光和电子显微镜和免疫荧光(IF)下观察到对大鼠肾组织的损伤。结果:PHN大鼠尿TxB_2明显高于对照组,但川li嗪处理的PHN大鼠蛋白尿,尿TxB_2和组织损伤明显减少,尿中6-keto-PGF_(1alpha),肾小球iNOS mRNA增加和未使用川gust嗪的PHN大鼠尿NO_2〜-/ NO_3〜-。结论:这些数据表明川gust嗪对PHN大鼠肾小球损伤具有抑制作用,可能与调节TxA_2-PGI_2的平衡并在一定程度上提高NO的合成有关。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号